Literature DB >> 25711510

Aripiprazole-Induced Hypoprolactinemia in an Adult Male with First-Episode Psychosis.

Alanna J Propst, G Eric Jarvis, Howard C Margolese.   

Abstract

Aripiprazole is an atypical antipsychotic that acts as a partial agonist at dopamine D2 receptors. Compared to other atypical antipsychotics, aripiprazole has less metabolic side effects and is less likely to increase prolactin. Moreover, it has been shown to have a unique prolactin lowering effect. While aripiprazole has been associated with subnormal prolactin levels in children, no documented cases of hypoprolactinemia in adults exist thus far. Here we report a case of aripiprazole-induced hypoprolactinemia in an adult male with first-episode psychosis, and the possible effects of abnormally low prolactin are discussed.

Entities:  

Keywords:  Aripiprazole; Hypoprolactinemia; Prolactin; Psychosis

Mesh:

Substances:

Year:  2015        PMID: 25711510     DOI: 10.3371/CSRP.PRJA.022015

Source DB:  PubMed          Journal:  Clin Schizophr Relat Psychoses        ISSN: 1935-1232


  3 in total

1.  Signal of Miscarriage with Aripiprazole: A Disproportionality Analysis of the Japanese Adverse Drug Event Report Database.

Authors:  Takamasa Sakai; Fumiko Ohtsu; Chiyo Mori; Kouichi Tanabe; Nobuyuki Goto
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

2.  TSH and PRL, side-effect markers in aripiprazole treatment: adjunctive aripiprazole-induced thyrotropin oversuppression in a young man with schizophrenia.

Authors:  Hidenobu Ohta; Satoru Inoue; Koichiro Hara; Akihiko Watanabe
Journal:  BMJ Case Rep       Date:  2017-08-22

3.  Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?

Authors:  Ya-Wen Jen; Tzung-Jeng Hwang; Hung-Yu Chan; Ming H Hsieh; Chen-Chung Liu; Chih-Min Liu; Hai-Gwo Hwu; Ching-Hua Kuo; Yi-Ting Lin; Yi-Ling Chien; Wei J Chen
Journal:  BMC Psychiatry       Date:  2020-11-23       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.